x |
| Savient Pharmaceuticals Experiencing Revenue Downtrend While its Industry is in an Uptrend |
|
Stock Quote: (NGM:SVNT) |
| 11/17/2009 |
|
| 12.81 |
+0.36 |
+2.89% |
743,141 |
|
| Savient Pharmaceuticals Experiencing Revenue Downtrend While its Industry is in an Uptrend |
|
| Last |
Price Change |
% Chg |
Volume |
|
|
New York, NY, November 17, 2009,T12-NEWS reports that Revenue for Savient Pharmaceuticals (NASDAQ:SVNT) for its trailing twelve months (TTM) ended September 30, 2009 was $3,194,000, a -19.59% decrease ... read full story |
|
|
|
|